| __timestamp | Arrowhead Pharmaceuticals, Inc. | BeiGene, Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 24419536 | 6930000 |
| Thursday, January 1, 2015 | 34718089 | 7311000 |
| Friday, January 1, 2016 | 40998209 | 20097000 |
| Sunday, January 1, 2017 | 32022880 | 62602000 |
| Monday, January 1, 2018 | 19110051 | 195385000 |
| Tuesday, January 1, 2019 | 26556257 | 388249000 |
| Wednesday, January 1, 2020 | 52275890 | 600176000 |
| Friday, January 1, 2021 | 80981000 | 990123000 |
| Saturday, January 1, 2022 | 124431000 | 1277852000 |
| Sunday, January 1, 2023 | 90932000 | 1504501000 |
| Monday, January 1, 2024 | 98761000 |
Data in motion
In the competitive world of biotechnology, managing costs is crucial for success. This chart compares the Selling, General, and Administrative (SG&A) expenses of BeiGene, Ltd. and Arrowhead Pharmaceuticals, Inc. from 2014 to 2023.
BeiGene, Ltd. has seen a staggering increase in SG&A expenses, growing from a modest $6.93 million in 2014 to a peak of $1.5 billion in 2023. This represents an astronomical growth of over 21,000%, reflecting the company's aggressive expansion and investment in its operations.
Arrowhead Pharmaceuticals, Inc. has experienced a more measured increase, with SG&A expenses rising from $24 million in 2014 to $124 million in 2022, marking a 417% increase. This steady growth indicates a more conservative approach to scaling operations.
The data for 2024 is incomplete, highlighting the dynamic nature of financial reporting in the biotech sector.
Vertex Pharmaceuticals Incorporated or Arrowhead Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Operational Costs Compared: SG&A Analysis of Zoetis Inc. and BeiGene, Ltd.
Comparing SG&A Expenses: GSK plc vs Arrowhead Pharmaceuticals, Inc. Trends and Insights
Teva Pharmaceutical Industries Limited vs Arrowhead Pharmaceuticals, Inc.: SG&A Expense Trends
BeiGene, Ltd. and Exelixis, Inc.: SG&A Spending Patterns Compared
Operational Costs Compared: SG&A Analysis of BeiGene, Ltd. and Viking Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of BeiGene, Ltd. and Xenon Pharmaceuticals Inc.
Dr. Reddy's Laboratories Limited and Arrowhead Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Comparing SG&A Expenses: Amneal Pharmaceuticals, Inc. vs Arrowhead Pharmaceuticals, Inc. Trends and Insights
Rhythm Pharmaceuticals, Inc. or Arrowhead Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Who Optimizes SG&A Costs Better? Arrowhead Pharmaceuticals, Inc. or Novavax, Inc.
SG&A Efficiency Analysis: Comparing Arrowhead Pharmaceuticals, Inc. and BioCryst Pharmaceuticals, Inc.